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ABSTRACT Some bacteria, when infected by their viral parasites (bacteriophages),
undergo a suicidal response that also terminates productive viral replication (abor-
tive infection [Abi]). This response can be viewed as an altruistic act protecting the
uninfected bacterial clonal population. Abortive infection can occur through the ac-
tion of type III protein-RNA toxin-antitoxin (TA) systems, such as ToxINPa from the
phytopathogen Pectobacterium atrosepticum. Rare spontaneous mutants evolved in
the generalized transducing phage M1, which escaped ToxINPa-mediated abortive
infection in P. atrosepticum. M1 is a member of the Podoviridae and a member of
the “KMV-like” viruses, a subset of the T7 supergroup. Genomic sequencing of M1
escape mutants revealed single-base changes which clustered in a single open read-
ing frame. The “escape” gene product, M1-23, was highly toxic to the host bacte-
rium when overexpressed, but mutations in M1-23 that enabled an escape pheno-
type caused M1-23 to be less toxic. M1-23 is encoded within the DNA metabolism
modular section of the phage genome, and when it was overexpressed, it copuriﬁed
with the host nucleotide excision repair protein UvrA. While the M1-23 protein inter-
acted with UvrA in coimmunoprecipitation assays, a UvrA mutant strain still aborted
M1, suggesting that the interaction is not critical for the type III TA Abi activity.
Additionally, M1 escaped a heterologous type III TA system (TenpINPl) from Photo-
rhabdus luminescens (reconstituted in P. atrosepticum) through mutations in the
same protein, M1-23. The mechanistic action of M1-23 is currently unknown, but fur-
ther analysis of this protein may provide insights into the mode of activation of
both systems.
IMPORTANCE Bacteriophages, the viral predators of bacteria, are the most abun-
dant biological entities and are important factors in driving bacterial evolution. In
order to survive infection by these viruses, bacteria have evolved numerous an-
tiphage mechanisms. Many of the studies involved in understanding these interac-
tions have led to the discovery of biotechnological and gene-editing tools, most no-
tably restriction enzymes and more recently the clustered regularly interspaced short
palindromic repeats (CRISPR)-Cas systems. Abortive infection is another such an-
tiphage mechanism that warrants further investigation. It is unique in that activation
of the system leads to the premature death of the infected cells. As bacteria in-
fected with the virus are destined to die, undergoing precocious suicide prevents
the release of progeny phage and protects the rest of the bacterial population. This
altruistic suicide can be caused by type III toxin-antitoxin systems, and understand-
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ing the activation mechanisms involved will provide deeper insight into the abortive
infection process.
KEYWORDS type III toxin-antitoxin, M1, Pectobacterium atrosepticum, abortive
infection, bacteriophage-bacterium interaction
It is estimated that there are more than 1030 bacteriophages (phages) on Earth,outnumbering their bacterial hosts 10-fold (1, 2). These large viral numbers generate
an estimated 1025 infections per second, imposing a large evolutionary selection
pressure on bacteria (2). In response, bacteria have evolved a plethora of defensive
mechanisms to counter these overwhelming phage insults (3). Consequently, phages
are continually evolving counterdefenses, and thus both the host and parasite are
locked together in a perpetual molecular arms race (4). Bacterial antiphage mechanisms
that have been observed include adsorption prevention, restriction-modiﬁcation sys-
tems, superinfection systems, abortive infection (Abi) systems, and the clustered reg-
ularly interspaced short palindromic repeats (CRISPR)-Cas systems (3). Studies of these
phage-host interactions have been translated into signiﬁcant molecular technologies
and reagents, most notably the use of restriction enzymes in cloning (5) and, more
recently, the CRISPR-Cas systems, the use of which is currently revolutionizing eukary-
otic molecular biology (6).
One of the more curious antiphage mechanisms is Abi, in which, postinfection, the
host bacterium is driven toward precocious cell death. This simultaneously terminates
viral replication and prevents a productive phage burst. Thus, the Abi response in
infected cells protects the bacterial population from progeny phage infection in a
process akin to an altruistic suicide (3). The majority of Abi systems have been studied
in Lactococcus lactis (7), an important bacterium in the dairy industry (8). Phage
contamination in fermentation cultures can cause substantial economic losses. Conse-
quently, considerable research has been conducted to identify and deﬁne many
antiphage systems useful for control of bacteriophages in lactococcal fermentations (7).
However, there are also well-studied Abi systems in other bacteria, such as Escherichia
coli, namely, the Rex, Lit, and PrrC systems (9–11). A commonly recurring theme of Abi
systems is that they involve the activation of a toxic protein that is suppressed under
normal growth conditions. However, environmental insults, phages, or other physio-
logical stresses can activate the toxin. Once activated, the toxin interferes with an
essential cellular process and induces bacteriostasis, ultimately leading to cell death.
This is a common feature shared by toxin-antitoxin (TA) systems (12).
TA systems were originally discovered on plasmids, where they function as plasmid
maintenance systems through postsegregational killing mechanisms (13). They have
been found in the majority of bacteria, both on plasmids (13) and chromosomally (14),
as well as in archaea (15) and phages (16). TA systems are typically bicistronic,
comprising a bacteriostatic or bactericidal toxic protein that is neutralized either
directly or indirectly by an antitoxin counterpart. To date, there are six TA system types
which are characterized by the nature and mode of action of their antitoxins (17). In the
case of type III TA systems, an RNA antitoxin directly interacts with the toxic protein to
form a nontoxic complex (18).
At least four types of TA systems confer phage resistance. These are the hok/sok
systems of type I (19), mazEF, rnlAB, and lsoAB of type II (20, 21), ToxINPa, TenpINPl, and
AbiQ of type III (22–24), AbiE of type IV (25), and sanaTA (which is currently not
characterized but likely to be a type II, having a proteinaceous antitoxin) (26). ToxINPa
was the ﬁrst type III system to be identiﬁed and originated from Pectobacterium
atrosepticum plasmid pECA1039. The toxin ToxNPa is encoded by toxN, and the anti-
toxin ToxIPa is encoded by toxI, a 36-nucleotide sequence repeated ﬁve and a half times
(22). The ToxINPa system provides protection against multiple phages infecting not only
its cognate host, P. atrosepticum, but also other enteric bacteria, including E. coli DH5
and Serratia marcescens Db11 (22). One such aborted pectobacterial phage is the
Myoviridae phage TE. TE phages that were no longer sensitive to ToxINPa had
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evolved to encode an RNA antitoxic mimic of ToxIPa, which was able to neutralize
ToxNPa (27). However, it did not shed light on how ToxINPa was activated during phage
infection. In fact, very little is known about the activation of any type III toxin-antitoxin
systems. The other type III system that has been studied for Abi is AbiQ from Lacto-
coccus lactis, which shows structural homology with ToxNPa (24). Three lactococcal
siphophages that were aborted by AbiQ have been examined in detail. However, all
had mutations in genes of unknown functions; orf38, m1, and e19 of phages P008,
bIL170, and c2, respectively (28). The AbiQ system was also reconstructed in a heter-
ologous host, E. coli MG1655, and was shown to confer resistance to a range of
coliphages, including T4 and T5. However, escape mutants could be obtained only for
a single phage (phage 2). Escape mutants of this phage showed mutations in orf210, a
predicted DNA polymerase (28). Studies of the AbiQ system suggests that there may be
multiple potential routes of escape involving several genes from different phages in the
activation of a single Abi system.
Previously it was shown that the pectobacterial phage M1 was aborted by the
ToxINPa system and was able to escape by evolving rare mutants (29).M1 was isolated
in 1995 during a search for new transducing phages effective as genetic tools in P.
atrosepticum (30). Here we characterize M1 and its escape mutants in depth. All M1
escape phages evolved through mutations in a gene encoding a small, highly toxic
protein, M1-23. When the related TenpINPl system of Photorhabdus luminescens was
transferred to P. atrosepticum, the system was able to abort M1 in the heterologous
host. Furthermore, it was possible to select spontaneous viral mutants that escaped
both ToxINPa and TenpINPl through mutations in M1-23.
RESULTS
M1 is a “KMV-like” virus. M1 is a generalized transducing phage of Pectobac-
terium atrosepticum (previously Erwinia carotovora subsp. atroseptica) (30). This podo-
virus is aborted by the type III TA system, ToxIN, from P. atrosepticum, namely, ToxINPa
(22). M1 generates spontaneous escape mutants that are resistant to Abi by ToxINPa
at a rate of 105 (29). In order to improve our understanding of ToxINPa-phage
interactions, we sequenced M1 wild type (wt) and three previously isolated escape
phages, M1-A, -B, and -D (29).
Using BLAST searches (31), M1 was classiﬁed as a member of the “KMV-like”
subgroup of the T7 supergroup of phages (32). T7-like phage linear genomes are
typically ﬂanked by direct terminal repeats (DTRs) (33). However, the DTRs could not be
deﬁned by a primer walking strategy along the M1 genome, consistent with results
from another KMV-like phage, LIMEzero (34). The presence and approximate size of the
DTRs, 293 bp, were therefore conﬁrmed through restriction digest analysis of the M1
genome (see Fig. S2 in the supplemental material). The ﬁnal M1 wild-type genome
was 43,827 bp long with a GC content of 49.30%. In comparison, the host P. atrosep-
ticum genome has a GC content of 50.97% (35). The two genomes therefore closely
match each other in GC content.
Global nucleotide alignments were performed to assess the relationship between
the KMV-like phages and M1. Compared with M1, phage VP93 (43,931 bp) (36),
phage LKA1 (41,593 bp) (32), phage LKD16 (43,200 bp) (32), andKMV itself (42,519 bp)
(33) shared between 48.2% and 49.2% sequence identity. These values match well
those of other KMV-like phages (34).
M1 contains 52 putative genes, named phiM1-1 to phiM1-52. The gene products
were named M1-1 to M1-52, and they are encoded by 92.6% of the genome. Subse-
quent BLASTp searches identiﬁed homologues for 32 of the open reading frames (ORFs)
from other KMV-like phages (Table S1). In most cases, it was therefore possible to assign
putative functions and categorize ORFs as containing either metabolism, structural, or
host lysis genes (Fig. 1A). M1 also encodes a single tRNAIle, between phiM1-38 and
phiM1-39.
M1 escape mutations had speciﬁc base substitutions. The genome sequences
of the three escape phages, M1-A, -B, and -D, were compared with that of the wt. All
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three escape phages had single point mutations localized to a 124-bp stretch (Fig. 1B),
across phiM1-22 and phiM1-23, which we refer to as the “escape locus.” To ascertain
whether these point substitutions were individual changes, further escape phages were
isolated using independent lysates to avoid the possibility of sibling mutants. The new
escape phage mutants were isolated following selection on P. atrosepticum pTA46
(ToxINPa) (22, 29). The escape locus of each phage was sequenced following ampliﬁ-
cation of the region from the puriﬁed genomic DNA. We observed that all 10 escape
phages had unique mutations distributed across 246 bp of the escape locus (Fig. 1B).
Nine of these mutations were base substitutions, while one was a single base deletion
(Table 1).
Infection with M1 affects the ToxIPa/ToxNPa ratio. Though it has been shown
that ToxNPa levels do not alter during a M1 phage infection (29), it was not known
how the ToxIPa levels were affected. The identiﬁcation of the escape phages provided
an opportunity to address this question. To investigate alterations to the ToxIPa/ToxNPa
ratio, we monitored the levels of ToxIPa and ToxNPa-FLAG during the infections by M1
and the escape phage M1-O within P. atrosepticum carrying a ToxINPa-FLAG plasmid
(pMJ4). Total protein and RNA samples were taken at different times after infection and
subjected to Western blotting and an S1 nuclease assay, respectively. While ToxNPa
levels stayed constant throughout infection (Fig. 2A, lower panel), ToxIPa levels dropped
dramatically after 30 min compared to those of an uninfected control (Fig. 2A).
Interestingly, ToxIPa levels increased back to original levels at 60 min. In comparison to
the infection with M1 wt, ToxIPa levels did not change signiﬁcantly at 30 min during
FIG 1 Genomic map of M1 wild type and its escape locus. (A) All 52 annotated ORFs are coded on the forward reading strand, in a linear
progression from metabolic genes to structural genes and, ﬁnally, to host cell lysis genes. Each forward reading frame is labeled F1, F2, or F3. ORFs
are shown to scale as shaded boxes numbered with the gene number, colored according to the predicted role. The single tRNAIle gene is
positioned on the scale, shown in purple. Where it was possible to identify a protein by homology searches, that ORF is labeled. The scale is in
base pairs. The ﬁgure was drawn to scale using Adobe Illustrator. (B) Schematic of the escape locus ofM1. All escape phage mutations are within
phiM1-23. Each forward reading frame is labeled F1, F2, or F3. Each ORF is shown to scale as a box, numbered with the gene number. Each stop
codon is represented as a green vertical line. The positions of the M1 escape phage mutations are shown by red vertical lines, labeled with the
parent phage. The scale is in base pairs.
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infection with the escape phage M1-O (Fig. 2B). The ToxIPa level did decrease with the
M1-O infection but only at 40 min (Fig. 2B). The ToxIPa levels were not then restored,
as in the case of M1 wt (Fig. 2B). M1 appears to activate ToxNPa, and thereby initiate
Abi, by causing a decrease in the cellular ToxIPa levels, either through direct or indirect
means. In the case ofM1-O, this activation is prevented due to the mutation in M1-23.
This would allow the phage to propagate, which may then account for the delayed
decrease and lack of restoration in ToxIPa levels.
Identiﬁcation and characterization of the M1 escape product. The majority of
escape mutations occurred within phiM1-23. On ﬁrst analysis, two mutations, those
from M1-B and M1-X, occurred at the 3= end of phiM1-22. Another mutation, from
M1-C, mapped further upstream, again within phiM1-22. This gene, phiM1-22, en-
codes a homologue of a putative DNA exonuclease from phage LKA1 (Table S1) (32).
Unfortunately, there were no database hits for phiM1-23 and phiM1-24, using either the
nucleotide or encoded protein sequences.
Speciﬁc regions of this escape locus were ampliﬁed from M1 phages and then
cloned into pBAD30 (37) to make inducible constructs (Fig. 3A and B). The cloning
began with constructs 1 to 6, using DNA from M1 wt and M1-B (Fig. 3B).
Constructs 1 and 2 could not be obtained with M1 wt DNA, presumably through
toxicity of the resulting wt constructs in E. coli DH5, but could be made using
TABLE 1 Summary of M1 escape mutations and effects on reading frames
Phage
Date of
isolation
Position and mutation
relative to M1 wta
Effect on forward reading frameb:
F1 F2 F3
M1-A March 2007 15416, A to C Y to S T to P No change
M1-B March 2007 15292, C to T R to stop No change P to L
M1-C March 2007 15170, T to C M to T Stop to S No change
M1-D March 2007 15410, T to C M to T W to R No change
M1-O June 2009 15407, A to C Q to P No change No change
M1-V May 2009 15415, T to G Y to D No change V to G
M1-W May 2009 15398, A to T D to V M to L Stop to C
M1-X May 2009 15288, AA to A FS to stop after 9 aa
(wild-type F1 continues
phiM1-23)
FS causing Q to H and stop after
3 aa (wild-type F2 stops after
9 aa)
FS causing N to T and shift of
ORF1 into ORF2 (wild-type
F3 stops after 3 aa)
M1-Y May 2009 15397, G to A
M1-Z May 2009 15416, A to G (cf. M1-A)
aMutations are indicated as, e.g., Y to S.
bFS, frameshift; aa, amino acid.
FIG 2 ToxIPa levels are affected during phage infection. (A) S1 nuclease assay targeting the full 5.5-repeat ToxIPa
sequence was used to monitor ToxIPa levels during M1 infection. Assays were performed on 10 g total RNA
prepared from P. atrosepticum ToxINPa (pMJ4) at different times following M1 infection. Numbers indicate the
time (minutes) after infection with phage (M1) and the negative control without phage (M1). Hybridization
to total RNA from P. atrosepticum expressing ToxINPa (pTA46) and DH5 served as positive and negative controls,
respectively. The expression of ToxNPa at the respective time points of infection is shown in the lower panel using
Western blotting; “C” indicates the 11-kDa SdhE-FLAG protein used as a loading and size control (54). (B) S1
nuclease assay targeting ToxIPa for the infection with the escape phage M1-O. The assay was done as described
for panel A.
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M1-B escape phage DNA. Constructs 3, 4, 5, and 6 could be made using both
sources of DNA. Due to the regions covered by these constructs, we could deter-
mine that within this locus, the genes of interest were phiM1-22 and phiM1-23 and
that phiM1-24 did not contribute to toxicity. As pBAD30 is tightly repressed by
FIG 3 Toxicity of theM1 escape locus products. (A) The escape locus ofM1 as described in the legend
to Fig. 1B. The positions of theM1 escape phage mutations are shown by red vertical lines, labeled with
the parent phage. The scale is in base pairs. (B) Speciﬁc regions of the phage genomes, designated by
the length of the line that corresponds to the genomic locus shown in panel A, were cloned into pBAD30
to make nine different constructs. Blue dashed lines in panel A reﬂect the construct boundaries in panel
B. The ﬁgure is drawn to scale. (C) Expression ofM1 wt andM1-B escape loci in P. atrosepticum. Strains
of P. atrosepticum containing either a ToxINPa or ToxINPa-FS plasmid (pTRB125 or pTRB126), together with
a phage construct (or pBAD30 vector control), were tested for toxicity. (D) A range of construct 7
plasmids was tested for toxicity in P. atrosepticum. The escape phage constructs were all reduced for
toxicity. Error bars show the standard deviations for triplicate data.
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glucose in E. coli DH5, this also implied that toxicity from this region of DNA might
be occurring via an internal promoter.
Upon ﬁrst analysis, the putative ATG start of phiM1-23 was at bp 15304. Taking into
account the stop codons of each frame (Fig. 1B, green vertical lines), the putative ATG
start codon of phiM1-23 could theoretically have been upstream of this initial annota-
tion. There were three possible ATG sites upstream of the putative start codon for
phiM1-23. The mutation of M1-C speciﬁcally altered the middle of these start codons
from M to T (Table 1). This start codon also had a ribosome binding site closer to
consensus than those of the other potential start codons, making it the most obvious
candidate. If this were the case, the escape mutations would span phiM1-23 speciﬁcally.
Constructs 7 to 9 were designed and made in order to test whether phiM1-23 alone
could generate a toxic phenotype.
We performed experiments to assess the toxicity of the escape locus constructs and
to determine whether toxicity was related to the presence of ToxINPa. P. atrosepticum
was transformed with inducible derivatives of the escape locus in combination with
either pBluescript-based (Fermentas) ToxINPa or negative-control ToxINPa-frameshift
(FS) vectors (pTRB125 and pTRB126, respectively). Serial dilutions of these dual-vector
strains of P. atrosepticum were then incubated with and without induction, overnight,
to determine the viable count (Fig. 3C). This clearly showed that the product of
construct 7, covering phiM1-23 speciﬁcally, was toxic. There was no toxicity in the case
of M1-B, the mutation in which causes a premature stop codon in phiM1-23. Toxicity
was also independent of the presence of ToxINPa. These results strongly suggested that
phiM1-23 produces a small, toxic protein, responsible either directly or indirectly for
activation of Abi against M1.
New versions of construct 7 (Fig. 3D) were then generated, with the addition of a
C-terminal FLAG tag to the M1-23 product, using both M1 wt and escape sequences.
Various constructs were then tested for toxicity in the cognate host, P. atrosepticum
(Fig. 3D). All the escape constructs tested showed reduced toxicity (Fig. 3D). It was
therefore possible to attempt overexpression and puriﬁcation of M1-23, using an E. coli
expression strain, ER2566. After expression trials using constructs made from M1 wt
and M1-O, -W, and -Y phage DNA, the M1-O-23FLAG product was chosen for further
study. Sufﬁcient M1-O-23FLAG protein was puriﬁed to allow mass spectrometry to
conﬁrm both the identity of the protein and, speciﬁcally, the presence of the expected
Q-to-P mutation. Furthermore, the protein sample was subjected to N-terminal se-
quencing, generating a sequence of TKM. This implied that phiM1-23 started at the ATG
speciﬁcally mutated by M1-C, as described earlier, and that the initial methionine is
cleaved posttranslationally. The annotation of the M1 wt genome was then altered to
accommodate phiM1-23 beginning at this conﬁrmed start codon. In summary, this
result shows that all the escape mutations map to a single gene, phiM1-23, which
generates a 9.8-kDa protein. These mutations reduce the toxicity of the protein product
and allow viral escape from ToxINPa-induced Abi.
It had not been possible to clone constructs 1 and 2 (Fig. 3B) using the M1 wt
sequence, despite the pBAD30 vector system being repressed in the presence of
glucose. This suggested that a promoter internal to those cloned regions might be
inducing the transcription of phiM1-23. A range of pRW50-based (38) lacZ transcrip-
tional fusion constructs was generated to investigate the possible presence of a
promoter (Fig. S3A). In this case, it was possible to clone the equivalent of construct 2
using M1 wt DNA (Fig. 3B), perhaps due to pRW50 having a low copy number, so the
level of toxicity was sufﬁciently low. Plasmid pTA104 (22), containing the promoter for
ToxINPa, was used as a positive control. All the test constructs except pTRB162, which
was an extremely truncated clone, generated LacZ activity (Fig. S3B). This conﬁrmed the
presence of a weak phiM1-23 promoter within phiM1-22.
Extensive analysis of M1 escape mutants map all mutations to phiM1-23. The
initial 10 escape mutants of M1 all had unique mutations in M1-23, so it was likely that
there were other possible mutations not yet observed. Identifying these other mutations
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could reveal important residues involved in the functionality of M1-23. Consequently, a
larger library of escape mutants was isolated and characterized in the same way as the
initial escape mutants. A total of 51 new, independent escape phages were isolated, and
their phiM1-23 sequences were characterized. All escape phages were shown to have
a mutation in this region, and several new unique escape phages were isolated (Table
S2). With the addition of these new escape phages, the number of different mutations
increased to 20. Interestingly, mutations in all three of the bases of the putative start
codon were isolated, consistent with this being the correctly annotated start site. Other
interesting mutations were those causing N-terminally located truncations of M1-23. In
particular, M1-E11 produced only a hypothetical dipeptide or indeed just a single
amino acid if the initial starting methionine was removed. Although most mutations in
M1-23 were missense alleles generating single amino acid residue changes, the ability
to isolate derivatives with major truncations showed that the M1-23 protein must be
nonessential for a productive M1 lytic cycle. Other notable mutations were M1-E48
and M1-E49 (both generating the same outcome), which modify the stop codon and
lead to a 10-amino-acid C-terminal extension. It is puzzling why the 10-mer extension
might impact function, because the addition of the octameric FLAG tag to the C
terminus of M1-23 did not disrupt protein toxicity. Perhaps the extension might harbor
a sequence that could act as an autoinhibitor or disrupt protein structure.
M1-23 interacts with UvrA, but abortive infection can still take place in UvrA-
deﬁcient P. atrosepticum. To assess whether there is a direct interaction of M1-23 with
the ToxINPa complex, His-tagged forms of both M1-23 and M1-O-23 were cloned,
allowing overexpression and puriﬁcation of these proteins. Coimmunoprecipitation
reactions were carried out, but the results showed no evidence for interactions be-
tween M1-23 and the ToxINPa complex and no impact of M1-23 on the ToxI RNA (data
not shown).
During the process of purifying M1-23-6His, it was noted that an additional high-
molecular-weight band that was not present in control samples appeared in the eluted
sample, and it was then copuriﬁed with M1-23 following ion-exchange fast perfor-
mance liquid chromatography (FPLC; data not shown). Mass spectrometric analysis
identiﬁed the host nucleotide excision repair protein, UvrA. Reciprocal coimmunopre-
cipitation assays were performed using puriﬁed protein samples to conﬁrm this inter-
action (Fig. 4). M1-23 protein retained UvrA, while M1-O-23 did not, and similarly, only
M1-23 was retained by immobilized UvrA (Fig. 4). This strongly suggests that M1-23 is
a viral product that is able to bind host UvrA.
To assess potential effects of UvrA on abortive infection, a uvrA mutant was
constructed in P. atrosepticum and conﬁrmed by sequencing and then by hypersensi-
FIG 4 Coimmunoprecipitation of M1-23, M1-O-23, and UvrA. (A and B) Coimmunoprecipitation experi-
ments with wild-type M1-23 and UvrA. (A) M1-23-6His was used as the bait and attached to a Ni column
with UvrA-FLAG passed through. (B) The reciprocal experiment was performed with UvrA-6His used as
the bait with M1-23-FLAG passed through. (C and D) The same coimmunoprecipitation experiments as
described for panels A and B but using M1-O-23 instead of M1-23. (C) M1-O-23 was used as bait; (D)
UvrA-6His was used as bait.
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tivity to UV light (Fig. S1). This strain was tested for its ability to abort M1 via the
ToxINPa system. Surprisingly, M1 was still aborted in the uvrAmutant and to the same
extent as in the wild-type P. atrosepticum strain (efﬁciency of plating [EOP] of M1 on
the uvrA mutant with ToxINPa, 1.1  105). Escape phages of M1 were isolated from
the uvrA mutant, and their DNA was sequenced. Interestingly, all escape phages
isolated on the uvrA mutant, M1-U1, -U2, and M1-U4 to M1-U10 (which were
independently isolated), carried mutations in the M1-23 sequence (Table S2). The
results suggest that although M1-23 clearly has a speciﬁc interaction with UvrA, it
appears that the escape route is either subtle or occurs indirectly.
The M1 escape mechanism works in another type III TA and Abi system. Two
further families of type III TA systems were recently identiﬁed, CptIN and TenpIN (23).
TenpINPl, from the chromosome of Photorhabdus luminescens TT01, was able to act as
an Abi system against coliphages when cloned on a multicopy plasmid and tested in
an E. coli background (23). By transforming P. atrosepticum SCRI1043 with the TenpINPl
expression plasmid, pFR2 (23), we were able to test three Pectobacterium phages
against the Abi activity of TenpINPl (Table 2). While S61 (29) and TE (27) were
dramatically affected by ToxINPa, neither were inhibited by TenpINPl (Table 2). This
indicates a degree of selectivity between the two Abi systems. M1, however, was
aborted by both systems, though to different degrees, which also underlines the
selectivity under which ToxINPa and TenpINPl appear to operate. As with ToxINPa, it was
possible to select for phages ofM1 that escaped Abi by TenpINPl. One of these escape
phages, M1-PL2, was isolated and sequenced. This escape phage had a single base
substitution, T15410C, the same mutation as in M1-D. To test this in reverse, escape
phageM1-O, selected with ToxINPa, was tested against TenpINPl (Table 2).M1-O was
also resistant to TenpINPl. These results imply that in the case of M1, the two systems
operate in a similar fashion with a single protein, M1-23, being a key mediator.
DISCUSSION
The pectobacterial phage M1 was shown previously to be sensitive to the ToxINPa
system and capable of producing spontaneous escape mutants (29). Here we found
that the M1 phage is also sensitive to TenpINPl when reconstructed in P. atrosepticum
and is correspondingly able to evolve escape mutants. This is the ﬁrst time we have
been able to identify a phage that is able to escape the TenpINPl system, and so further
study may provide information about its activation. Interestingly, the M1 phage is
insensitive to two other type III systems tested, ToxINBt from Bacillus thuringiensis and
the CptINEr system from Eubacterium rectale (data not shown), and no Abi activity
has so far been observed in these two systems (23, 39). In contrast, the P.
atrosepticum phage TE is aborted by ToxINPa and able to escape the system by
RNA-based molecular mimicry of the antitoxin (27) but is not aborted by the
TenpINPl system (Table 2).
Characterization of the M1 phage in this study has shown that all escape mutants
selected on ToxINPa or TenpINPl have mutations in a gene encoding M1-23. Alteration
of single amino acids, extreme truncations due to very 5= stop codons, or even stop
codon mutations leading to short C-terminal extensions of M1-23 cause insensitivity to
both ToxINPa and TenpINPl. Escape mutants selected on one system are also insensitive
to the other system, suggesting that there is a common pathway for the M1 phage
in the activation of these two systems. The role of M1-23 is unknown, but it was shown
TABLE 2 EOPs against ToxINPa and TenpINPl type III TA systems
Phage EOP vs ToxINPa EOP vs TenpINPl
System on which escape
was selected
M1 wt 1.3  105 1.1  102
S61 3.2  109 0.9
TE 1.0  108 0.7
M1-O 1.0 1.0 ToxINPa
M1-PL2 0.9 0.9 TenpINPl
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to be nonessential, and as it is located between a predicted exonuclease gene,
phiM1-22, and a predicted endonuclease gene, phiM1-25, it might have a role in the
regulation of nucleases or indeed may be able to act as a nuclease itself. In a previous
study, it was shown that ToxNPa levels do not change during infection of the M1
phage (29). In this study, we found that the ToxIPa levels decrease 30 min postinfection.
In contrast, during the infection by the M1 escape phage M1-O, ToxIPa levels
decreased only slightly after 40 min and were not restored. It appears that wild-type
M1 activates ToxNPa by decreasing the levels of ToxIPa and therefore initiating Abi. For
M1-O, the mutation in M1-23 prevents this early activation and thereby provides a
window of opportunity for the phage to replicate.
To investigate the mechanism of M1-23 action, a large number of M1 escape
phages were isolated and their phiM1-23 regions were sequenced. The results showed
a number of escape mutations near the 5= end of the gene, resulting in extremely
truncated versions of the protein. This conﬁrms that M1-23 is a nonessential viral
protein. However, the majority of mutations found were toward the 3= region of the
gene and were mostly missense mutations resulting in single amino acid changes,
implying that the C-terminal domain of the protein is important for Abi functionality.
To further characterize M1-23, it was overexpressed and puriﬁed, but due to high
toxicity, only a small amount of protein could be produced. Using the limited amount
of protein available, interaction studies were performed to see if M1-23 interacted with
ToxINPa. During puriﬁcation of M1-23, a high-molecular-weight protein always copuri-
ﬁed. Mass spectrometry of this protein conﬁrmed that it was the DNA repair protein
UvrA. It was shown through coimmunoprecipitation experiments that while M1-23
could interact with UvrA, the escape version of the protein M1-O-23 could not.
UvrA forms part of the SOS response in bacteria, a DNA damage response pathway
(40) that has previously been shown to be involved in TA activation. The type I TA
system TisB-IstR is under direct SOS response control, as tisAB, which encodes the TisB
toxin, contains a LexA operator region that is inhibited by LexA (41). In addition to the
SOS response, the stringent response has also been shown to play a role in the
activation of TA systems. Both type I and type II TA systems have been shown to be
regulated by (p)ppGpp, the central regulator of the stringent response (42, 43). How-
ever, M1 and TE were tested in a (p)ppGpp-negative double mutant (relA spoT) and
were still aborted in that background (data not shown).
During the course of this study, the genomes of two new pectobacterial phages
were sequenced. These were P. atrosepticum phage Peat1 (44) (GenBank accession
number KR604693) and P. carotovorum phage PPWS1 (45) (DDBJ accession number
LC063634). Both of these were podoviruses that shared high sequence identity to M1.
Peat1 (45,633 bp) shared 77.7% sequence identity, and PPWS1 (44,539 bp) shared
59.7% sequence identity. Furthermore, analysis of the two genomes revealed that both
phages encoded M1-23 homologs, with the Peat1 homolog differing by only a single
amino acid. Therefore, it is highly likely that both phages would be aborted by both the
ToxINPa and TenpINPl systems and evolve escapes in the same way. If this was the case,
it would show a common route through which phages of different bacteria are able to
escape the same system.
Both ToxINPa and TenpINPl are very powerful antiphage abortive infection systems
that belong to two different families of type III TA systems and are effective against a
wide variety of phages. While many phages show differing sensitivities to the two
systems, this study has shown that in M1, there is a common pathway through which
these two families of type III TA systems can be activated. This pathway involves a small
toxic protein, M1-23, of unknown metabolic function that does not directly interact
with the ToxINPa complex but that interacts directly with UvrA. M1 infection causes
a diminution in ToxIPa levels, presumably leading to the destabilization of the ToxINPa
complex and consequent liberation of ToxNPa to induce cell death and concomitant
abortive infection of the viral parasite.
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MATERIALS AND METHODS
Bacterial strains, bacteriophages, and growth conditions. Bacterial strains and bacteriophages are
listed in Table 3. E. coli strains were grown at 37°C, and Pectobacterium atrosepticum SCRI1043 (35) was
grown either at 25°C on agar plates or at 25, 28, or 30°C as required for liquid culture in Luria broth (LB)
at 250 rpm or on LB agar (LBA). LBA contained 1.5% (wt/vol) or 0.35% (wt/vol) agar, to make LBA plates
or top-LBA, respectively. Bacterial growth was measured using a spectrophotometer set to 600 nm. When
required, media were supplemented with ampicillin (Ap) at 100 g ml1, chloramphenicol (Cm) at 50 g
ml1, kanamycin (Km) at 50 g ml1, tetracycline (Tc) at 10 g ml1, isopropyl -D-thiogalactopyranoside
(IPTG) at 0.5 mM, or 2, 6-diaminopimelic acid (DAPA) at 300 M. Spontaneous escape phage mutants
were isolated as described previously (27). Phage lysates were made as described previously (46). Phages
were stored at 4°C in phage buffer, i.e., 10 mM Tris-HCl (pH 7.4), 10 mM MgSO4, and 0.01% (wt/vol)
gelatin. A few drops of chloroform saturated with sodium bicarbonate was also added to the phage
lysates to maintain sterility. EOP was calculated after overnight incubation of serial dilutions of phage
lysates in a top-LBA lawn of each bacterial host and recorded as the number of PFU on the test strain
relative to the number of PFU on the control strain. EOPs were calculated using P. atrosepticum wt or a
frame-shifted toxN plasmid strain as the negative control (22).
M1 genomic sequencing. Bacteriophage DNA was extracted with phenol-chloroform, using Phase
Lock Gel tubes (Eppendorf) and in accordance with the manufacturer’s instructions, as for bacteriophage
. The extracted DNA was subjected to pyrosequencing on a Roche 454 Genome Sequencer FLX at the
DNA sequencing facility, Department of Biochemistry, University of Cambridge. Contiguous read seg-
ments (contigs) were assembled using Newbler (Roche). The M1 wild-type sequence was determined
in one lane of the sequencing run. The three escape phage genomes were individually tagged with
independent identifying sequences and then combined and sequenced as a mixture within a second
lane. For each of the four phages, the ﬁnal assembled sequence consisted of a single contig of
approximately 43,500 bp. The average read length was 250 bp. The wild-type sequence was assembled
from 13,628 reads, leading to approximately 78 coverage of the full sequence. Escape phage M1-A,
-B, and -D sequences were assembled from 4,925, 5,188, and 5,886 reads, respectively, resulting in
approximately 29 coverage of each sequence.
When the sequence data are viewed, beginning at bp 43572 (in the ﬁnal M1 wt sequence), there
are 15 tandem repeats of the 2-bp sequence TG. The number of TG repeats varied between the raw
TABLE 3 Bacterial strains and bacteriophages used in this study
Bacterium or phage Genotype or characteristics
Reference
or source
Bacteria
Escherichia coli 2163 F RP4-2-Tc::Mu dapA::(erm-pir) Kmr 57
E. coli DH5 F endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG purB20 80dlacZΔM15
Δ(lacZYA-argF)U169 hsdR17(rK mK) 
Gibco/BRL
E. coli ER2566 F  fhuA2 [lon] ompT lacZ::T7 gene 1 gal sulA11 Δ(mcrC-mrr)114::IS10
R(mcr-73::miniTn10-TetS)2 R(zgb-210::Tn10) (TetS) endA1 [dcm]
NEB
E. coli W3100 F  rph-1 INV(rrhD, rrhE) 58
Pectobacterium atrosepticum
SCRI1043
Wild-type strain 35
Phages
M1 Podoviridae, propagated on wt SCRI1043 30
M1-A ToxINPa escape mutant of M1 29
M1-B ToxINPa escape mutant of M1 29
M1-C ToxINPa escape mutant of M1 29
M1-D ToxINPa escape mutant of M1 29
M1-O ToxINPa escape mutant of M1 This study
M1-V ToxINPa escape mutant of M1 This study
M1-W ToxINPa escape mutant of M1 This study
M1-X ToxINPa escape mutant of M1 This study
M1-Y ToxINPa escape mutant of M1 This study
M1-Z ToxINPa escape mutant of M1 This study
M1-Q ToxINPa escape mutant of M1 This study
M1-E1 to -E49 ToxINPa escape mutant of M1 This study
M1-U1 ToxINPa escape mutant of M1 on UvrA mutant This study
M1-U2 ToxINPa escape mutant of M1 on UvrA mutant This study
M1-U4 ToxINPa escape mutant of M1 on UvrA mutant This study
M1-U5 ToxINPa escape mutant of M1 on UvrA mutant This study
M1-U6 ToxINPa escape mutant of M1 on UvrA mutant This study
M1-U7 ToxINPa escape mutant of M1 on UvrA mutant This study
M1-U8 ToxINPa escape mutant of M1 on UvrA mutant This study
M1-U9 ToxINPa escape mutant of M1 on UvrA mutant This study
M1-U10 ToxINPa escape mutant of M1 on UvrA mutant This study
M1-PL2 TenpINPl escape mutant of M1 This study
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sequences of each phage, from 17 in M1-A to 1 in M1-B and 7 in M1-D. The exact number of TG
repeats in each phage genome could not be accurately conﬁrmed by sequencing a speciﬁc amplicon.
Therefore, in order to sequence this region, it was speciﬁcally ampliﬁed (primers TRB107/TRB108 and
TRB115/TRB116) and cloned into pBR322 (NEB). From the resulting plasmid DNA, the region was
successfully sequenced on both forward and reverse strands.
Potential ORFs were identiﬁed using gene prediction tools such as ORFﬁnder (https://www.ncbi.nlm
.nih.gov/orfﬁnder/), GeneMark.hmm (47), and Glimmer (48), along with BLAST (31) homology searches
and manual annotation. RBSﬁnder (49) was used to predict ribosome-binding sites (see Table S1 in the
supplemental material). M1 tRNAs were identiﬁed using tRNAScan-SE (50). The BDGP Neural Network
Promoter Prediction (51) program did not identify any consensus promoters. The program Stretcher,
from the EMBOSS suite (http://www.ebi.ac.uk/Tools/psa/emboss_stretcher/nucleotide.html), was used
for global nucleotide alignments. The M1 genome was viewed and annotated using Artemis (52).
Plasmid construction. Molecular biology techniques were performed as described previously (53).
All primers were obtained from Sigma-Genosys and Invitrogen and are listed in Table 4. All plasmids
constructed and/or used in this study are listed in Table 5, along with the primers used for their
construction. All recombinant plasmid sequences were veriﬁed by DNA sequencing.
Measuring ToxIPa and ToxNPa levels during phage infection. Two cultures of 180 ml of LB
containing Ap were inoculated with 2-ml overnight cultures of P. atrosepticum(pBR322) or P. atrosepti-
cum(pMJ4), respectively. Cultures were grown at 25°C and shaken at 180 rpm to an optical density at 600
nm (OD600) of 1, and each was split into two 80-ml volumes, one of which was infected with phage at
a multiplicity of infection (MOI) of 1, while the other served as a negative control without infection.
Cultures were left for 10 min without shaking for phage adsorption and then shaken at 25°C and 180
rpm. Samples for OD600 measurement, RNA preparation, and protein analysis were taken regularly during
infection. Total RNA was isolated using the TRIzol method and subsequently DNase treated. Cell pellets
for Western blot analysis were resuspended in 1 phosphate-buffered saline (PBS) according to the
OD600 measurement.
Western blot analysis of ToxNPa during infection. One-milliliter samples of the cell cultures were
taken, pelleted, and resuspended in 1 PBS according to the OD600. For samples taken during M1
phage infection, the protein was quantiﬁed using a NanoDrop spectrophotometer (ThermoScientiﬁc),
and equal amounts of protein (150 g) were resolved by 12% PAGE. Proteins were transferred to a
polyvinylidene diﬂuoride (PVDF) membrane and blocked for 1 h in 1 PBS containing 5% milk powder.
Immunodetection of FLAG-tagged ToxN was performed overnight at 4°C in 1 PBS using anti-FLAG M2
antibody (Sigma). Goat anti-mouse IgG-horseradish peroxidase (HRP) (Santa Cruz) was used as a
secondary antibody. Bands were visualized on X-ray ﬁlm using the SuperSignal West Pico chemilumi-
TABLE 4 Primers used in this study
Primer Sequence (5=–3=) Description
Restriction
site
KDOI TTTTGGATCCGTTTTATCGACATTGTGAACC toxIN locus BamHI
PF147 GTATCTAGAGTAGTCGCCTCTTTTACTTTATTAC toxI XbaI
PF217 TTGTATACTTAAGTTATTGACTCTATAGCTCAG ToxI ampliﬁcation for S1 nuclease
protection assay
HindIII
PF218 TTGACTATGTAGTCGCCTCTTTTACTTTATTTCGAACCTCGGACCTGCG ToxI ampliﬁcation for S1 nuclease
protection assay
DrdI
TRB37 CCGGCATATGAAATTCTACACTATATCAAGC Used for ToxIN CBD NdeI
TRB38 GTGGTTGCTCTTCCGCACTCGCCTTCTTCCGTAT Used for ToxIN CBD SapI
TRB107 TTGAATTCTGCGCAAGCAACTGGTGCACC M1 sequencing primer EcoRI
TRB108 TTAAGCTTCTTGAATCTGTACTCACCG M1 sequencing primer HindIII
TRB111 TTGAATTCCTGTAGGAGCGTGGAATGC M1 escape locus EcoRI
TRB115 TTGAATTCCAGGGGTGTTACCTACTCC M1 sequencing primer EcoRI
TRB116 TTAAGCTTGTAACTGTGCAGTGATACC M1 sequencing primer HindIII
TRB117 TTGAATTCCCTACAATGCCCCAGATGC M1 escape locus EcoRI
TRB118 TTAAGCTTACGGTCGTACTTGGCTTCG M1 escape locus HindIII
TRB125 TTAAGCTTCTAATCCTACGCCTTGTGC M1 escape locus HindIII
TRB126 TTGAATTCAAGGTGGATGCAACTCGGG M1 escape locus EcoRI
TRB127 TTAAGCTTCTCTACATCATCCAACATC M1 escape locus HindIII
TRB128 TTGAATTCGAGCTGCGTGATGAGTTCC M1 escape locus EcoRI
TRB129 TTGAATTCGCTTACCCGATTATATCC M1 escape locus EcoRI
TRB130 TTGAATTCCCAATTTAAAATTAATGA M1 escape locus EcoRI
TRB134 TTAAGCTTATTACTTGTCATCGTCGTCCTTGTAGTCTCCTAGGTACCCCATCTGG M1 construct 7/ORF23 FLAG HindIII
TRB135 TTAAGCTTAGTGATGGTGATGGTGATGTCCTCCTAGGTACCCCATCTGG M1 construct 7/ORF23-6His HindIII
TRB332 TTAAGCTTATTACTTGTCATCGTCGTCCTTGTAGTCTCCCAGCATCGGCTTAAGGAAGCG uvrA-FLAG HindIII
TRB337 ATTAGGATCCGATAAGATCGAAGTTCG uvrA primer BamHI
TRB338 ATTAAAGCTTTTACAGCATCGGCTTAAG uvrA primer HindIII
UvrA dnF TTTATTCCGGGAAGTGTGTGAATTTAAATTAGCGAGAGGCCAAATCATG Fwd, 500 bp downstream of uvrA SwaI
UvrA dnR TTATCAGAATTCCTGCCGTGCAGGCAGTTCAG Rev, 500 bp downstream of uvrA EcoRI
UvrA upF TTATCATCTAGATTGCAGTGCGCCTTCGATG Fwd, 500 bp upstream of uvrA XbaI
UvrA upR CATGATTTGGCCTCTCGCTAATTTAAATTCACACACTTCCCGGAATAAA Rev, 500 bp upstream of uvrA SwaI
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nescent substrate kit (Pierce). SdhE-FLAG expressed from pMAT7 (54) was used as a control in the blot
tracking M1 infection.
S1 nuclease protection assays. An antisense probe covering the complete ToxIPa sequence was
made by ampliﬁcation of the ToxIPa locus from plasmid pTA110, using primers PF217 and PF218, and
subsequent in vitro transcription and gel extraction of the probe as described previously (55), generating
a uniformly [32P]UTP-labeled antisense transcript. Ten micrograms of DNase-treated total RNA was
hybridized to the antisense probe overnight at 68°C in a total volume of 30 l containing 22% or 6%
formamide for the M1 or M1-O total RNA, respectively, 40 mM PIPES [piperazine-N,N=-bis(2-
ethanesulfonic acid)]-KOH (pH 6.4), 1 mM EDTA, and 400 mM NaCl. Reaction mixtures were treated with
S1 nuclease (Invitrogen) (1 U l1) for 1.5 h at 37°C in a total volume of 300 l 1 S1 nuclease buffer
to degrade any single-stranded nucleic acids. Double-stranded hybridization products were precipitated,
resuspended, and resolved by 10% PAGE. Bands were visualized by phosphorimaging (Bio-Rad Personal
FX phosphorimager).
Toxicity assays.When required, media were supplemented with Ap, D-glucose (glu) at 0.2% (wt/vol),
and L-arabinose (L-ara) at 0.1% (wt/vol). P. atrosepticum strains containing two plasmids were grown as
10-ml overnight cultures, used to inoculate 25 ml LB, Ap, Cm, and glu in 250-ml conical ﬂasks, and grown
at 25°C and 250 rpm, from a starting OD600 of 0.04, until exponential phase (1  108 CFU ml1).
TABLE 5 Plasmids used in this study
Name Description
Construction source or
primers Template Resistance
pACYC184 Cloning vector 59 Cm
pBR322 E. coli cloning vector NEB Ap, Tc
pFR2 Photorhabdus luminescens TT01 full TenpINPl locus 23 pBR322 Ap
pKNG-uvrA UvrA marker exchange construct UvrA upF, UvrA upR, UvrA dnF,
UvrA dnR
pKNG101 Tc, Kan
pKNG101-Tcr Marker exchange suicide vector 60 Tc
pMAT7 SdhE-FLAG expression vector 54 pBAD30 Ap
pMJ4 ToxIPa, ToxNPa-FLAG with native promoter in pBR322 29 pBR322 Ap
pQE80L Protein expression vector Qiagen Ap
pRW50 Promoterless LacZ 38 Tc
pTA46 ToxINPa with native promoter 29 pBR322 Ap
pTA104 ToxINPa promoter 22 pRW50 Tc
pTA110 In vitro transcription vector for antisense ToxIPa RNA PF217, PF218 pBSII SK Ap
pTRB18-KP14 ToxIPa containing KDO1, PF147 pACYC184 Cm, Tc
pTRB14 ToxNPa CBD TRB37, TRB38 pTA46 Ap
pTRB113 M1 wt construct 3 TRB126, TRB118 pBAD30 Ap, glu
pTRB114 M1 wt construct 4 TRB117, TRB127 pBAD30 Ap, glu
pTRB115 M1 wt construct 5 TRB126, TRB125 pBAD30 Ap, glu
pTRB116 M1 wt construct 6 TRB128, TRB118 pBAD30 Ap, glu
pTRB121 M1-B construct 2 TRB117, TRB125 pBAD30 Ap, glu
pTRB123 M1-B construct 4 TRB117, TRB127 pBAD30 Ap, glu
pTRB124 M1-B construct 5 TRB126, TRB125 pBAD30 Ap, glu`
pTRB133 M1 wt construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB134 M1 wt construct 8 TRB129, TRB125 pBAD30 Ap, glu
pTRB135 M1 wt construct 9 TRB130, TRB125 pBAD30 Ap, glu
pTRB136 M1-A construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB139 M1-B construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB140 M1-B construct 8 TRB129, TRB125 pBAD30 Ap, glu
pTRB141 M1-B construct 9 TRB130, TRB125 pBAD30 Ap, glu
pTRB148 M1 wt construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu
pTRB151 M1-O construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu
pTRB153 M1-W construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu
pTRB154 M1-Y construct 7-FLAG TRB111, TRB134 pBAD30 Ap, glu
pTRB155 M1-D construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB156 M1-O construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB157 M1-V construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB158 M1-W construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB159 M1-Y construct 7 TRB111, TRB125 pBAD30 Ap, glu
pTRB160 M1 wt LacZ fusion construct TRB117, TRB127 pRW50 Tc
pTRB161 M1 wt LacZ fusion construct TRB111, TRB127 pRW50 Tc
pTRB162 M1 wt LacZ fusion construct TRB126, TRB127 pRW50 Tc
pTRB163 M1-O LacZ fusion construct TRB117, TRB125 pRW50 Tc
pTRB164 M1 wt LacZ fusion construct TRB117, TRB125 pRW50 Tc
pTRB189 M1-23-6His TRB111, TRB135 pQE-80L Ap
pTRB190 M1-O-23-6His TRB111, TRB135 pQE-80L Ap
pTRB300 UvrA-FLAG TRB330, TRB332 pBAD33 Cm, glu
pTRB301 UvrA-6His TRB337, TRB338 pQE-80L Ap
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Samples were removed, washed with PBS, serially diluted, and plated for viable counts at 25°C on
LBA-Ap-Cm plates containing either (i) glu, to repress expression, or (ii) L-ara, to induce expression.
Single-plasmid strains were treated in the same way, except that Cm was omitted from the growth
conditions.
-Galactosidase assays. Liquid assays for LacZ activity were performed using the substrate 4=-
methylumbelliferyl--D-glucuronide (MUG) as described before (56). Brieﬂy, samples of culture (150 l)
were taken at each time point and frozen at80°C until required. Ten-microliter aliquots of each sample
culture were frozen at 80°C for 10 min and then thawed at room temperature. Next, 100 l reaction
buffer (PBS, 400 g ml1 lysozyme, 250 g ml1 MUG) was added, and samples were immediately
monitored in a Gemini XPS plate reader with the following parameters: excitation, 360 nm; emission, 450
nm; cutoff, 435 nm; eight reads per well; measurements taken every 30 s for 30 min. Relative ﬂuorescence
units min1 was calculated from a period of linear increase in ﬂuorescence, normalized to the OD600 of
the sample.
Pulldown of ToxINPa and M1-23 from cell lysates. Using M1 and M1-O genomic DNA, M1-23
and M1-O-23 were ampliﬁed via PCR using TRB111 and TRB135 as primers. The products were then
digested using the relevant restriction enzymes, ligated into pQE-80L, and then used to transform
ER2566. For the ToxINPa strains, pMJ4 (which contains ToxINPa-FLAG) was used, and a new plasmid was
constructed to make a ToxNPa-chitin binding domain (CBD) fusion. This was produced using pTA46 and
primers TRB37 and TRB38. The plasmid pTRB14 was then used to transform ER2566, which had previously
been transformed with pTRB18-KP14, which contains a ToxIPa sequence.
Expression strains were grown in 2 YT medium (per liter, 16 g tryptone, 10 g yeast extract, 5 g NaCl)
at 37°C until an OD600 of approximately 1. The cultures were then induced with the appropriate
supplement (0.5 mM IPTG for M1-23-6His and M1-O-23-6His) and then left to grow overnight at 18°C. No
inducers were added to the tagged ToxINPa-containing strains, as ToxINPa is constitutively expressed on
pBR322.
Cells were harvested by centrifugation at 8,000  g, and the pellets were resuspended in 10 ml lysis
buffer (50 mM NaH2PO4·2H2O, 500 mM NaCl, 10 mM imidazole, 10% glycerol, pH 8.0) per 500 ml of
original culture volume. Cells were then lysed by four passes through a high-pressure homogenizer
(EmulsiFlex; at up to 15,000 lb/in2). Lysed cells were centrifuged at 8,000  g, and the supernatants were
kept for further coimmunoprecipitation experiments.
In the experiments using M1-23-6His and M1-O-23-6His as bait, 1.5 ml Ni2 resin columns were used
with ToxINPa-FLAG. The columns were equilibrated using 3 column volumes (CV) of lysis buffer before the
His-tagged protein lysates were loaded onto the resin. Loaded resins were washed with 5 CV of wash
buffer 1 (20 mM imidazole), followed by 10 CV of wash buffer 2 (40 mM imidazole). The FLAG-tagged
ToxINPa was then loaded onto the appropriate columns via continuous ﬂow for at least 3 h (often
overnight) before washing with 5 CV wash buffer 1 and 10 CV wash buffer 2.
Samples were eluted from the resin using elution buffer (250 mM imidazole) via three 1-ml fractions
and analyzed by Western blot analysis using antibodies against His (Novagen) and FLAG (Sigma) tags.
Brieﬂy, samples were run on 12.5% Tris-Tricine gels and transferred onto Immobilon-P PVDF membranes
(pore size, 0.45 m; Millipore) at 250 mA for 90 min. Membranes were then blocked with a 5% milk plus
PBST (PBS with Tween 20) solution for 1 h before incubation with anti-His and anti-FLAG antibodies at
1:10,000 for 2 h. After incubation, the membranes were washed three times for 5 min each in PBST and
then incubated with the secondary anti-mouse antibody (Sigma) at 1:10,000 for 1 h before they were
washed again three times for 5 min each in PBST. The blots were then probed with Immobilon-Western
chemiluminescent HRP-substrate (Millipore) and developed.
For experiments in which ToxINPa was used as the bait, the strain expressing ToxINPa-CBD was used
with 1 ml chitin resin. The protocol and buffers used were as described by the manufacturer (NEB). Brieﬂy,
the ToxINPa-CBD lysate was loaded onto the column and washed with 40 ml of column buffer. The M1-23
or control pQE-80L lysates were then added to their respective columns. The columns were washed twice
with 10 ml and then 27 ml of column buffer, followed by a dithiothreitol (DTT) ﬂush, 5 to 7 ml for 10 min.
Columns were then left to incubate overnight at room temperature. After incubation, elution was carried
out using 15 ml of column buffer. Western blot analyses were then performed on the samples as
previously described.
Measuring ToxIPa levels after ToxINPa pulldown with M1-23. ToxIPa levels were measured in the
eluted fractions of the ToxINPa-CBD chitin resin column experiments. Samples from cultures either
expressing M1-23 or containing the pQE-80L vector control were separated by electrophoresis at 80 V,
using a 1% (wt/vol) agarose gel made with 0.5 TAE (Tris-acetate-EDTA). Additionally, samples were also
measured with a NanoDrop spectrophotometer (Labtech; ND-1000).
Coimmunoprecipitation of UvrA and M1-23. UvrA-6His was constructed by ampliﬁcation from the
E. coli W3110 genome using primers TRB337 and TRB338. PCR products were then digested with the
appropriate restriction enzymes, and the digested product was puriﬁed and then ligated into pQE-80L
to generate UvrA with an N-terminal His tag, pTRB301. This plasmid was then used to transform the E.
coli expression strain ER2566. Likewise, UvrA-FLAG was constructed in a similar way but using primers
TRB330 and TRB332 and ligated into pBAD33.
Expression and subsequent experiments were performed as described earlier using His-tagged
proteins as bait on Ni2 resin. Expression of UvrA-FLAG was induced by the addition of 0.02% arabinose.
Construction of the P. atrosepticum uvrA mutant. The uvrA mutant of P. atrosepticum was
constructed via allelic exchange. This was performed using the plasmid pKNG-uvrA, which was derived
from pKNG101. The plasmid was constructed by ﬁrst amplifying 500-bp regions up- and downstream of
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the uvrA gene in P. atrosepticum SCRI1043. These two sequences were then ligated together with a
kanamycin cassette inserted in between.
The suicide vector derivative pKNG-uvrA was used to transform E. coli 2163 and grown overnight
in the appropriate selective medium. This served as the donor strain and, along with an overnight culture
of the recipient strain, P. atrosepticum SCRI1043, was pelleted and resuspended in LB. Both cultures were
then mixed at the ratios of 2:1, 1:1, and 1:2 up to a ﬁnal volume of 100 l. The resulting mixtures
were then spotted on DAPA-containing plates and incubated at 25°C for 24 h. After mating, the patches
were resuspended in 100 l LB, serially diluted, and spread onto LBA plates containing tetracycline.
These plates were incubated for 2 days at 25°C, and colonies that appeared were picked and grown in
LB overnight. The subsequent overnight cultures were serially diluted, and 50-l samples were plated
onto LBA plates containing 10% (wt/vol) sucrose. Colonies were also patched onto LBA plates containing
kanamycin, and the gene deletion was conﬁrmed using colony PCR and DNA sequencing. The strain was
conﬁrmed phenotypically as UvrA negative by demonstrating a hypersensitivity to UV light (see Fig. S1
in the supplemental material).
Accession number(s). The genome of M1 has been submitted to GenBank under the accession
number JX290549.
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